These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 2988732

  • 1. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E, Boyko WJ, Willoughby B, Constance PD, Wiggs B, O'Shaughnessy M, Sharp FR.
    Can Med Assoc J; 1985 Jul 15; 133(2):111-2. PubMed ID: 2988732
    [Abstract] [Full Text] [Related]

  • 2. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
    Boyko WJ, Schechter MT, Jeffries E, Douglas B, Maynard M, O'Shaughnessy M.
    Can Med Assoc J; 1985 Jul 01; 133(1):28-32. PubMed ID: 2988730
    [Abstract] [Full Text] [Related]

  • 3. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM, Salahuddin SZ, Markham PD, Joseph LJ, Payne SM, Kriebel P, Bernstein DC, Biddison WE, Sarngadharan MG, Gallo RC.
    J Clin Invest; 1985 Oct 01; 76(4):1699-704. PubMed ID: 2997287
    [Abstract] [Full Text] [Related]

  • 4. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D, v d Helm K, Abb J, Eberle J, Zoulek G, Pleyl G, Deinhardt F, Riethmüller G, Ziegler-Heitbrock HW, Rieber EP.
    Dtsch Med Wochenschr; 1984 Nov 09; 109(45):1709-11. PubMed ID: 6094134
    [Abstract] [Full Text] [Related]

  • 5. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ, Sarngadharan MG, Biggar RJ, Weiss SH, Winn DM, Grossman RJ, Greene MH, Bodner AJ, Mann DL, Strong DM.
    Lancet; 1984 Sep 29; 2(8405):711-6. PubMed ID: 6148471
    [Abstract] [Full Text] [Related]

  • 6. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
    Jeffries E, Willoughby B, Boyko WJ, Schechter MT, Wiggs B, Fay S, O'Shaughnessy M.
    Can Med Assoc J; 1985 Jun 15; 132(12):1373-7. PubMed ID: 2988729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG, Ponce de León S, Ruiz Palacios G, Tinoco JC, Calva JJ, Zamora EE.
    Salud Publica Mex; 1986 Jun 15; 28(2):180-5. PubMed ID: 3014666
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS.
    Biberfeld P, Porwit-Ksiazek A, Böttiger B, Morfeldt-Månsson L, Biberfeld G.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4665s-4670s. PubMed ID: 2410110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Mar 14; 35(10):152-5. PubMed ID: 3005822
    [Abstract] [Full Text] [Related]

  • 18. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
    Krohn K, Ranki A, Antonen J, Valle SL, Suni J, Vaheri A, Saxinger C, Gallo RC.
    Clin Exp Immunol; 1985 Apr 14; 60(1):17-24. PubMed ID: 2988832
    [Abstract] [Full Text] [Related]

  • 19. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J, Vogt M, Bhushan R, Lüthy R, Haller O, Joller H, Ferber T, Büchner S, Schuppli R, Schädelin J.
    Schweiz Med Wochenschr; 1985 Jul 27; 115(30):1048-54. PubMed ID: 2994208
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.